I think this is a complex issue when adults have a history of not robust dental health / oral hygeine and then have chemotherapy, as this is when research suggests risk of ONJ is greater. Extraction of one suspicious tooth before zometa does not mean another will not give problems later during treatment.
Also the risk in relation to fractures is not absolute. It is about treating a population of people with MM with bisphosphonates to reduce a risk of fracture in the population as a whole. Some people start off with stronger bones, others have weaker bones or multiple bone lesions which strengthening of bones would benefit. Myeloma specialists also point out that zometa has a potential small anti myeloma effect and increases survival by a little.
As with any preventative treatment the benefits will outweigh the risks for some individuals and not others due to side effects and their pre-existing state of disease/ health. That is why it is important to look at the whole picture as an individual trying to make a decision and then accept the decision.